fluorodeoxyglucose f18 has been researched along with HIV-Associated Lipodystrophy Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caton, MT; Hyun, H; Miskin, N | 1 |
Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Sass, CA; Stavrou, E; Torriani, M | 1 |
Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Stavrou, E; Torriani, M; Zanni, MV | 1 |
Bleeker-Rovers, CP; Corstens, FH; de Geus-Oei, LF; Koopmans, PP; Oyen, WJ; Smits, P; van der Ven, AJ; Zomer, B | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and HIV-Associated Lipodystrophy Syndrome
Article | Year |
---|---|
18F-FDG Uptake in Subcutaneous Fat Preceding Clinical Diagnosis of Human Immunodeficiency Virus-Associated Lipodystrophy.
Topics: Fluorodeoxyglucose F18; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Subcutaneous Fat | 2018 |
Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome.
Topics: Adipose Tissue, Brown; Adiposity; Atrophy; Back; Biopsy; Cohort Studies; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Middle Aged; Multimodal Imaging; Obesity, Abdominal; Positron-Emission Tomography; Subcutaneous Fat; Tissue Distribution; Tomography, X-Ray Computed; Up-Regulation | 2012 |
Increased FDG uptake in association with reduced extremity fat in HIV patients.
Topics: Abdominal Fat; Body Composition; Extremities; Fluorodeoxyglucose F18; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Subcutaneous Fat; Tomography, X-Ray Computed | 2013 |
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Blood Glucose; Fluorodeoxyglucose F18; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2004 |